Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,280.50
+29.50 (1.31%)
At close: Mar 6, 2026
Rohto Pharmaceutical Market Cap
Rohto Pharmaceutical has a market cap or net worth of 515.31 billion as of March 6, 2026. Its market cap has decreased by -7.82% in one year.
Market Cap
515.31B
Enterprise Value
510.40B
Revenue
335.80B
Ranking
n/a
PE Ratio
15.35
Stock Price
2,280.50
Market Cap Chart
Since July 4, 1997, Rohto Pharmaceutical's market cap has increased from 64.95B to 515.31B, an increase of 693.44%. That is a compound annual growth rate of 7.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 515.31B | -13.22% |
| Dec 30, 2025 | 593.83B | -9.54% |
| Dec 30, 2024 | 656.47B | 1.21% |
| Dec 29, 2023 | 648.60B | 22.54% |
| Dec 30, 2022 | 529.28B | 33.52% |
| Dec 30, 2021 | 396.39B | 13.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.64T |
| Shiseido Company | 1.21T |
| Lion Corporation | 483.86B |
| Kobayashi Pharmaceutical | 419.05B |
| KOSE Holdings | 325.33B |
| Paltac | 292.90B |
| Pola Orbis Holdings | 291.96B |
| MTG Co., Ltd. | 234.29B |